Non-Surgical Nerve Control
New Injectable Device Controls Nerves Without Surgery, Offering Less Invasive Therapies
Scientists have developed a nerve-control device so small it can be injected through a standard needle — no surgery, no wires, no battery required. The device, called SEED (Stimulating Electrode for Electroceutical Delivery), was published on June 12, 2026 in the journal *Science Advances* by researchers from NYU Abu Dhabi and Cleveland Clinic Abu Dhabi, according to El Periódico.
The breakthrough could transform how doctors treat chronic pain and movement disorders. Instead of a major operation, a doctor could inject a tiny implant directly near a nerve in an outpatient clinic. More than 51.6 million Americans live with chronic pain, and millions more suffer from conditions like Parkinson's disease, according to Levante-EMV.
A Tiny Seed Injected Straight to the Nerve
The SEED device fits through a 14-gauge needle — the same size used in everyday clinical procedures. Once inside the body, it sits next to a nerve and delivers electrical pulses to control pain or movement signals. There are no leads, no wires, and no battery pack. That alone sets it apart from every nerve stimulator currently in use, according to Diario de Mallorca.
The device runs on a technology called magnetoquasistatic resonant inductive coupling. In plain terms, it harvests energy from a low-frequency magnetic field — just 65 kilohertz — sent from an external transmitter worn outside the body. That frequency is low enough to pass safely through bone and tissue without heating it, according to La Provincia.
Surgery-Free Care for Millions With Chronic Pain
Today's nerve stimulators require full surgery to implant. Doctors must insert bulky battery packs and long wire leads. Those leads often break or shift inside the body, forcing patients back into the operating room. The SEED device eliminates all of that, according to LNE.
Prof. Khalil Ramadi, the study's senior author at NYU Abu Dhabi, put it simply. "By creating a device that can be injected rather than surgically implanted, we are making these therapies simpler, safer, and more accessible, while still maintaining precise control over nerve activity," he said, as reported by El Periódico Mediterráneo. Because no operating room is needed, the procedure could eventually reach clinics in underserved areas that lack surgical infrastructure.
A Decade of Research Behind This Single Injection
This breakthrough did not happen overnight. In 2020, Jacob Robinson's team at Rice University published a study showing a grain-of-rice-sized film that converts magnetic energy into electrical voltage. By August 2025, his team had tested a wireless network of miniature implants in large animals, publishing results in *Nature Biomedical Engineering*, according to El Día.
The 2026 SEED device is the first version engineered specifically to be injected through a needle. Some future versions are being designed to bioresorb — meaning they dissolve naturally in the body after doing their job. That would make them fully temporary, leaving nothing behind, according to Diario Córdoba.
Real Hurdles Still Stand Between Lab and Patient
Experts caution that serious questions remain. Without wires to anchor them, these tiny implants could move inside the body over time. Current animal studies show the devices are visible under ultrasound, making it possible to track them — but long-term data in humans does not yet exist, according to La Opinión de A Coruña.
Regulatory approval is another barrier. Device biocompatibility and safety trials take years. Dr. Sawsan Abdel-Razig of Cleveland Clinic Abu Dhabi stressed the partnership's focus on "clinically relevant research that translates into meaningful improvements in patient care," as cited by El Periódico de Extremadura. Human translational trials are expected to begin next, but a timeline for clinical use has not been confirmed.
Sentiment
NeutralPublishers
11
Articles
0
Reach
11
